National Institute for Health and Clinical Excellence (NICE)
NICE welcomes new senior executive team appointments
New Chief Medical Officer, Chief People Officer and Director of Implementation and Partnerships appointed by NICE
NICE is pleased to welcome several new appointments to senior roles within the organisation, including a new Chief Medical Officer, Chief People Officer and Director of Implementation and Partnerships.
The new appointments are:
- Professor Jonathan Benger CBE, who has joined the NICE Executive Team as our new Chief Medical Officer (CMO).
- Helen Brown as our Chief People Officer
- Clare Morgan as our Director of Implementation and Partnerships.
Professor Jonathan Benger CBE joined NICE earlier this month. He is the former Chief Medical Officer of NHS Digital, and for the past six months has been the interim Chief Clinical Information Officer (CCIO) for NHS England. Between May 2013 and July 2019 Jonathan was the National Clinical Director for Urgent and Emergency Care at NHS England.
In his clinical work, Jonathan is a Consultant in Emergency Medicine at the Bristol Royal Infirmary and does regular shifts with the Great Western Air Ambulance which he founded as its first Clinical Director in 2007. He is also Professor of Emergency Care in the School of Health and Social Wellbeing at the University of the West of England, and a National Institute for Health Research (NIHR) Senior Investigator.
Jonathan takes over from Dr Gail Allsopp who has returned to the Royal College of General Practitioners (RCGP).
Helen Brown has over 25 years of experience in human resources and has held a variety of HR roles. Initially, Helen built her career in the retail industry and over the last 12 years has worked within MedTech for Medtronic. Within Medtronic Helen has served as the HR Director looking after three business units across Europe in neuroscience. Prior to this, she worked as HR Director for the UK and Ireland.
In her roles Helen has ensured close alignment with business strategies and has been heavily involved in transformation. She is a fellow of the CIPD and holds a Diploma in HR Management and a BA (Hons) in Sociology and Social Policy from Durham University and has also completed a certificate programme in organisational development with NTL.
Dr Clare Morgan joins NICE from her role as Director of Strategy at Liverpool University Hospitals NHS Foundation Trust, leading on organisation and system wide strategy, transformation and partnerships in an integrated care system responsible for tackling some of the worst health inequalities in the UK and Europe. Prior to this Clare was the national research delivery director for the NIHR Clinical Research Network for 13 years, during which she spent a year in the South Yorkshire & Bassetlaw Integrated Care System leading on research and innovation. She also brings significant experience of the clinical research ecosystem, gained through roles in contract research organisations, the pharmaceutical industry and within academia.
Dr Sam Roberts, NICE chief executive said: "I am very pleased to welcome all of our new appointments to their roles, I know they will make significant contributions which will help NICE continue to get the best care to patients, ensure value for money for the taxpayer, and help us create useful and useable advice for the NHS.
“Jonathan’s extensive experience as a health system leader and frontline doctor in the NHS will be a great asset to our team. Helen is a dedicated and adaptable leader with a proven track record of driving transformation and delivering pragmatic solutions to complex challenges and Clare is a compassionate, wise manager who brings a deep understanding of the realities of the NHS, which I know will be invaluable.
"I would also like to thank Gail for her tremendous work with us; her knowledge, positivity and creativity during her time with NICE proved vital. I’m looking forward to continuing to work with Gail as a valued partner in her role at the RCGP."
Naomi Lee also joins in a new role of Head of Organisational Transformation. She was previously Senior Executive Editor at The Lancet and has a passion for using health research and data to improve people’s lives through medical science.
In addition, Boryana Stambolova has been appointed as our interim Director of Finance and Helen Knight is substantively appointed as Director of Medicines Evaluation.
Original article link: https://www.nice.org.uk/News/Article/nice-welcomes-new-senior-executive-team-appointments
Latest News from
National Institute for Health and Clinical Excellence (NICE)
NICE recommends genetic test to prevent newborn babies going deaf31/03/2023 09:25:00
A genetic test to establish if a newborn baby is vulnerable to deafness if treated with a commonly used antibiotic has been recommended by NICE in final guidance.
Hundreds of people are set to receive the first immunotherapy drug for advanced cervical cancer through the Cancer Drugs Fund30/03/2023 11:05:00
Hundreds of people with cervical cancer are set to receive the first immunotherapy drug for an advanced form of the disease as NICE yesterday (Wednesday 29 March 2023) published the final draft guidance recommending its use in the Cancer Drugs Fund (CDF).
NICE identifies improvements for people with acute kidney injury in updated quality standard23/03/2023 15:30:00
An updated quality standard published today (23 March 2023) by NICE outlines improvements in care for people who have or are at risk of acute kidney injury
NICE recommends life-changing gene therapy for children with ultra-rare genetic disorder in final draft guidance23/03/2023 13:15:00
The first and currently only gene therapy for children with an ultra-rare genetic disorder has been recommended by NICE in final draft guidance published today (23 March 2023).
Four innovative tests for diagnosing UTIs could help in the fight against antimicrobial resistance21/03/2023 14:15:00
Innovative tests with the potential to help people with a urinary tract infection (UTI) receive the correct course of antibiotics more quickly could soon be considered for use in the NHS.
NICE recommended weight-loss drug to be made available in specialist NHS services08/03/2023 14:20:00
Thousands of people will soon be able to be prescribed a drug to help them lose weight as part of their treatment in an NHS specialist weight management service.
Eight digitally enabled therapies to treat depression and anxiety in adults conditionally recommended by NICE01/03/2023 13:20:00
Eight digital enabled therapies to treat depression and anxiety disorders in adults have been conditionally recommended by NICE in draft guidance issued today (Wednesday 1 March 2023)
NICE recommends 3 treatments for COVID-19 in final draft guidance21/02/2023 13:05:00
Everyone with COVID-19 at highest risk of developing severe disease will have access to clinically and cost-effective treatments, under final draft guidance published by NICE today.
NICE says evidence that COVID-19 treatment Evusheld is effective in protecting vulnerable adults against current variants is lacking as it announces new rapid update process for COVID-19 medicines16/02/2023 11:25:00
NICE has today (16 February 2023) issued draft guidance for public consultation which does not recommend Evusheld for preventing COVID-19 in adults who are unlikely to have an adequate immune response to COVID-19 vaccination, or who can’t be vaccinated